JP2011251985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011251985A5 JP2011251985A5 JP2011157930A JP2011157930A JP2011251985A5 JP 2011251985 A5 JP2011251985 A5 JP 2011251985A5 JP 2011157930 A JP2011157930 A JP 2011157930A JP 2011157930 A JP2011157930 A JP 2011157930A JP 2011251985 A5 JP2011251985 A5 JP 2011251985A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrate
- pharmaceutically acceptable
- acceptable salt
- hydroxamic acid
- batch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 8
- 239000002245 particle Substances 0.000 claims 6
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 claims 6
- 229960000237 vorinostat Drugs 0.000 claims 6
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003931 anilides Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68287505P | 2005-05-20 | 2005-05-20 | |
| US60/682,875 | 2005-05-20 | ||
| US69312805P | 2005-06-23 | 2005-06-23 | |
| US60/693,128 | 2005-06-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007540436A Division JP5264174B2 (ja) | 2005-05-20 | 2006-05-16 | スベロイルアニリドヒドロキサム酸の製剤及びこれを作製するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011251985A JP2011251985A (ja) | 2011-12-15 |
| JP2011251985A5 true JP2011251985A5 (enrdf_load_stackoverflow) | 2012-10-04 |
| JP5308486B2 JP5308486B2 (ja) | 2013-10-09 |
Family
ID=37452585
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007540436A Active JP5264174B2 (ja) | 2005-05-20 | 2006-05-16 | スベロイルアニリドヒドロキサム酸の製剤及びこれを作製するための方法 |
| JP2011157930A Active JP5308486B2 (ja) | 2005-05-20 | 2011-07-19 | スベロイルアニリドヒドロキサム酸の製剤及びこれを作製するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007540436A Active JP5264174B2 (ja) | 2005-05-20 | 2006-05-16 | スベロイルアニリドヒドロキサム酸の製剤及びこれを作製するための方法 |
Country Status (20)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI415603B (zh) * | 2005-05-20 | 2013-11-21 | Merck Sharp & Dohme | １，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法 |
| AU2009305214B2 (en) | 2008-10-15 | 2015-06-25 | Generics [Uk] Limited | Process for the preparation of vorinostat |
| JP2012509929A (ja) * | 2008-11-26 | 2012-04-26 | ジェネリクス・（ユーケー）・リミテッド | 多型 |
| EP2362870A2 (en) * | 2008-11-26 | 2011-09-07 | Generics [UK] Limited | Novel processes and pure polymorphs |
| US20110313044A1 (en) * | 2010-06-18 | 2011-12-22 | Urquima S.A. | Polymorphs of Suberoylanilide Hydroxamic Acid |
| EP3484470A4 (en) | 2016-07-13 | 2020-02-26 | Technion Research & Development Foundation Limited | INHIBITORS OF HISTONE DEACETYLASE 4 CYTOPLASMIC COMPLEX FOR THE TREATMENT OR PREVENTION OF VASCULAR OR VALVULAR CALCIFICATION |
| CN107362148B (zh) * | 2017-07-27 | 2020-04-21 | 东曜药业有限公司 | 一种治疗肿瘤的药物组合物及其制备方法和应用 |
| EP4007585A4 (en) | 2019-08-02 | 2023-11-08 | OneHealthCompany, Inc. | TREATMENT OF CANCER IN DOGS |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| JPS61176523A (ja) | 1985-01-30 | 1986-08-08 | Teruhiko Beppu | 制癌剤 |
| US5175191A (en) | 1988-11-14 | 1992-12-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| US5608108A (en) | 1988-11-14 | 1997-03-04 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
| US5055608A (en) | 1988-11-14 | 1991-10-08 | Sloan-Kettering Institute For Cancer Research | Novel potent inducers of thermal differentiation and method of use thereof |
| US5700811A (en) | 1991-10-04 | 1997-12-23 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
| US5369108A (en) | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| USRE38506E1 (en) | 1991-10-04 | 2004-04-20 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| US5635532A (en) | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| JP3170069B2 (ja) * | 1992-10-06 | 2001-05-28 | 日水製薬株式会社 | 徐放性顆粒剤 |
| US6043389A (en) | 1997-03-11 | 2000-03-28 | Mor Research Applications, Ltd. | Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| US6124495A (en) | 1997-03-11 | 2000-09-26 | Beacon Laboratories, Inc. | Unsaturated oxyalkylene esters and uses thereof |
| US6030961A (en) | 1997-03-11 | 2000-02-29 | Bar-Ilan Research & Development Co., Ltd. | Oxyalkylene phosphate compounds and uses thereof |
| US6231880B1 (en) | 1997-05-30 | 2001-05-15 | Susan P. Perrine | Compositions and administration of compositions for the treatment of blood disorders |
| AUPO721997A0 (en) | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
| US6262116B1 (en) | 1998-01-23 | 2001-07-17 | Sloan-Kettering Institute For Cancer Research | Transcription therapy for cancers |
| HK1042308A1 (zh) | 1998-10-13 | 2002-08-09 | 藤泽药品工业株式会社 | 環四肽化合物及其用途 |
| AU6718200A (en) | 1999-05-03 | 2000-12-12 | Methylgene, Inc. | Inhibition of histone deacetylase |
| JP2001081031A (ja) | 1999-08-30 | 2001-03-27 | Schering Ag | 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤 |
| EA200601252A1 (ru) | 1999-09-08 | 2006-10-27 | Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч | Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения |
| KR20020070285A (ko) | 1999-11-23 | 2002-09-05 | 메틸진, 인크. | 히스톤 디아세틸라제의 억제제 |
| EP1280764B1 (en) | 2000-03-24 | 2010-11-24 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| AU2001285042A1 (en) | 2000-08-18 | 2002-03-04 | The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor |
| PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| EP2292593A3 (en) | 2000-09-29 | 2011-05-25 | TopoTarget UK Limited | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| WO2002055017A2 (en) | 2000-11-21 | 2002-07-18 | Wake Forest University | Method of treating autoimmune diseases |
| AR035659A1 (es) | 2000-12-07 | 2004-06-23 | Hoffmann La Roche | Hidroxiamidas de acido (1-oxo-1,2,3,4-tetrahidro-naftalen-2-il)-alcanoico, proceso para la manufactura de estos compuestos, composiciones farmaceuticas que contienen dichos compuestos y los usos de los mismos |
| US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
| US6905669B2 (en) | 2001-04-24 | 2005-06-14 | Supergen, Inc. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
| CA2450129A1 (en) | 2001-06-14 | 2002-12-27 | Donald G. Jackson | Novel human histone deacetylases |
| EP2269609A3 (en) | 2001-10-16 | 2012-07-11 | Sloan-Kettering Institute for Cancer Research | Treatment of neurodegenerative diseases and cancer of the brain with SAHA |
| US20040132643A1 (en) | 2002-01-09 | 2004-07-08 | Fojo Antonio Tito | Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| JP2005525345A (ja) | 2002-02-15 | 2005-08-25 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Ｔｒｘ媒介性疾患を処置する方法 |
| US20070060614A1 (en) | 2002-03-04 | 2007-03-15 | Bacopoulos Nicholas G | Methods of treating cancer with hdac inhibitors |
| US20040132825A1 (en) * | 2002-03-04 | 2004-07-08 | Bacopoulos Nicholas G. | Methods of treating cancer with HDAC inhibitors |
| US7456219B2 (en) * | 2002-03-04 | 2008-11-25 | Merck Hdac Research, Llc | Polymorphs of suberoylanilide hydroxamic acid |
| CA2632078C (en) | 2002-03-04 | 2012-08-14 | Sloan-Kettering Institute For Cancer Research | Methods of inducing terminal differentiation |
| US20060276547A1 (en) | 2002-03-04 | 2006-12-07 | Bacopoulos Nicholas G | Methods of treating cancer with HDAC inhibitors |
| US7148257B2 (en) | 2002-03-04 | 2006-12-12 | Merck Hdac Research, Llc | Methods of treating mesothelioma with suberoylanilide hydroxamic acid |
| CA2482508A1 (en) | 2002-04-15 | 2003-10-30 | Sloan-Kettering Institute For Cancer Research | Combination therapy for the treatment of cancer |
| DE10218106A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen von Arzneimittelwirkstoffen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| CA2506504A1 (en) | 2002-11-20 | 2004-06-03 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
| CN1839121A (zh) | 2003-04-01 | 2006-09-27 | 斯隆-凯特林癌症研究所 | 异羟肟酸化合物及其使用方法 |
| HRP20060080A2 (en) | 2003-08-26 | 2006-07-31 | Sloan-Kettering Institute For Cancer Research | Method of treating cancer with hdac inhibitors |
| TWI415603B (zh) * | 2005-05-20 | 2013-11-21 | Merck Sharp & Dohme | １，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法 |
| US20090227674A1 (en) | 2005-08-18 | 2009-09-10 | Richon Victoria M | Combination methods fo saha and targretin for treating cancer |
| CA2622136A1 (en) | 2005-11-04 | 2007-05-18 | Merck & Co., Inc. | Methods of using saha and erlotinib for treating cancer |
| US20070117815A1 (en) | 2005-11-04 | 2007-05-24 | James Pluda | Method of treating cancers with SAHA and pemetrexed |
| CA2626679C (en) | 2005-11-04 | 2011-08-16 | Merck & Co., Inc. | Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies |
-
2006
- 2006-05-11 TW TW099119337A patent/TWI415603B/zh not_active IP Right Cessation
- 2006-05-11 TW TW095116824A patent/TWI365068B/zh not_active IP Right Cessation
- 2006-05-15 DO DO2006000113A patent/DOP2006000113A/es unknown
- 2006-05-16 EP EP06759843A patent/EP1853245A2/en not_active Ceased
- 2006-05-16 WO PCT/US2006/018737 patent/WO2006127319A2/en active Application Filing
- 2006-05-16 WO PCT/US2006/018795 patent/WO2006127321A2/en active Application Filing
- 2006-05-16 NZ NZ553204A patent/NZ553204A/en not_active IP Right Cessation
- 2006-05-16 MX MX2007002047A patent/MX2007002047A/es active IP Right Grant
- 2006-05-16 AU AU2006249440A patent/AU2006249440C1/en active Active
- 2006-05-16 US US11/663,165 patent/US8093295B2/en active Active
- 2006-05-16 NZ NZ594669A patent/NZ594669A/xx not_active IP Right Cessation
- 2006-05-16 BR BRPI0605893-0A patent/BRPI0605893A/pt not_active IP Right Cessation
- 2006-05-16 KR KR1020077003998A patent/KR100884500B1/ko not_active Expired - Fee Related
- 2006-05-16 KR KR1020087030074A patent/KR100993135B1/ko not_active Expired - Fee Related
- 2006-05-16 CA CA2580367A patent/CA2580367C/en active Active
- 2006-05-16 JP JP2007540436A patent/JP5264174B2/ja active Active
- 2006-05-16 PE PE2006000515A patent/PE20061390A1/es not_active Application Discontinuation
- 2006-05-16 EP EP10183861A patent/EP2292221A3/en not_active Withdrawn
- 2006-05-17 AR ARP060101986A patent/AR055953A1/es not_active Application Discontinuation
- 2006-05-17 MY MYPI20062258A patent/MY144613A/en unknown
-
2007
- 2007-01-30 IL IL181070A patent/IL181070A0/en unknown
- 2007-02-02 NI NI200700031A patent/NI200700031A/es unknown
- 2007-02-07 CR CR8912A patent/CR8912A/es unknown
- 2007-02-16 EC EC2007007263A patent/ECSP077263A/es unknown
- 2007-02-16 MA MA29685A patent/MA28804B1/fr unknown
-
2009
- 2009-04-27 AU AU2009201652A patent/AU2009201652B2/en not_active Ceased
- 2009-04-27 AU AU2009201650A patent/AU2009201650B2/en not_active Ceased
-
2010
- 2010-01-13 US US12/686,843 patent/US8450372B2/en active Active
- 2010-01-13 US US12/686,830 patent/US20100113829A1/en not_active Abandoned
- 2010-01-13 US US12/686,812 patent/US8288440B2/en active Active
-
2011
- 2011-07-19 JP JP2011157930A patent/JP5308486B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011251985A5 (enrdf_load_stackoverflow) | ||
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| JP2014515013A5 (enrdf_load_stackoverflow) | ||
| JP2012021008A5 (enrdf_load_stackoverflow) | ||
| JP2013032389A5 (enrdf_load_stackoverflow) | ||
| JP2015145426A5 (enrdf_load_stackoverflow) | ||
| JP2017537066A5 (enrdf_load_stackoverflow) | ||
| MX2012003204A (es) | Forma de dosificacion solida oral que contiene nanoparticulas y proceso para su formulacion utilizando gelatina de pescado. | |
| JP2012255026A5 (enrdf_load_stackoverflow) | ||
| JP2012067110A5 (enrdf_load_stackoverflow) | ||
| JP2014500861A5 (enrdf_load_stackoverflow) | ||
| JP2012524724A5 (enrdf_load_stackoverflow) | ||
| JP2015525757A5 (enrdf_load_stackoverflow) | ||
| JP2014167010A5 (enrdf_load_stackoverflow) | ||
| JP2012132799A5 (enrdf_load_stackoverflow) | ||
| JP2016534081A5 (ja) | ゾレドロン酸の増強された経口バイオアベイラビリティーを有する経口剤形を調製する方法 | |
| EP2832350A4 (en) | METHOD FOR PRODUCING A CRACKING PARTICULAR COMPOSITION WITH ACIDIC CARBOXYMETHYL CELLULOSE, CRACKING PARTICULAR COMPOSITION WITH ACIDIC CARBOXYMETHYL CELLULOSE AND MOUTH - CRACKING TABLET WITH THE DECAPITIVE PARTICULAR COMPOSITION WITH ACIDIC CARBOXYMETHYL CELLULOSE | |
| JP2015526577A5 (enrdf_load_stackoverflow) | ||
| JP2014097964A5 (enrdf_load_stackoverflow) | ||
| TN2012000435A1 (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| JP2012087043A5 (ja) | 微小針状構造物 | |
| JP2014511374A5 (enrdf_load_stackoverflow) | ||
| CA2899024C (en) | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid | |
| JP2017505809A5 (enrdf_load_stackoverflow) | ||
| CR8912A (es) | Formulaciones de acido hidroxamico suberoilanilida y procedimientos para la produccion de las mismas |